Amid the growing novel coronavirus infections across the world, Indian manufacturers of Reverse transcription-polymerase chain reaction (RT-PCR) kits, used for COVID-19 testing, are ready to export their products to foreign markets including Latin America, East Asia, and Eastern Europe.
The move comes after the Indian government allowed restricted shipment of these test kits earlier in August.
In India, the manufacturing capacity is of 1 billion RT-PCR kits, said the report. After diagnostic companies complained that they were left with surplus inventory as their stocks were not picked by state governments, the Centre allowed limited exports of these kits, it said.
However, the Directorate General of Foreign Trade (DGFT) has fixed export quotas of these kits at 10 million for August, the report suggested.
“There is still a huge global shortage of these kits. We will be applying for an export quota as we have got orders from the United Nations to test their peacekeeping forces,” Sriram Natarajan, the chief executive of Goa-based Molbio Diagnostics told the publication.
Besides export of test kits, the company is also in the process of applying for emergency authorisation approval from the US Food and Drug Administration to launch its TrueNat test devices in that market, Natarajan was quoted as saying.
Other companies such as Mylab and Huwel Lifesciences are also expected to apply for export licences, said the report. – Moneycontrol